Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Nikkei jumps to over 1-month high

2018-07-18 thehindubusinessline
Japan's Nikkei share average soared to a more than one-month high on Wednesday morning as exporters such as automakers and technology firms got a boost after the dollar hit a six-month high against the yen.
7261 PCRFY 9681 ADTTF MZDAY TM TYT TOYOF 2531 TTDKF TKHIY MZDAF 7203 ATEYY

0
Nikkei rises to more than 1-month high as exporters get boost from weak yen

2018-07-18 reuters
* Takara, Tokyo Dome fall after brokerage takes guess to be excluded from Nikkei index in Oct
7261 PCRFY 9681 ADTTF MZDAY TM TYT TOYOF 2531 TTDKF TKHIY MZDAF 7203 ATEYY

0
Panasonic Says It's Open to Working With Tesla on China Factory - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VLKAF PCRFY TM 7203 TYT TOYOF

14
Hell for Elon Musk Is a Midsize Sedan - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PCRFY GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF

0
Panasonic plans to halve cobalt content of car batteries in 2 to 3 years - Channel NewsAsia

2018-07-12 channelnewsasia
TOKYO: Panasonic Corp plans to halve the cobalt content of its mass-produced automotive batteries "in two to three years", an executive at the Japanese conglomerate said on Thursday (Jul 12), as battery makers look to reduce costs.
PCRFY

0
Panasonic plans to halve cobalt content of car batteries in two-three years

2018-07-12 reuters
TOKYO (Reuters) - Panasonic Corp (6752.T) plans to halve the cobalt content of its mass-produced automotive batteries “in two to three years”, an executive at the Japanese conglomerate said on Thursday, as battery makers look to reduce costs.
PCRFY

14
5 things to know about Tesla's China plans

2018-07-12 nzherald.co.nz
BEIJING (AP) — Electric vehicle producer Tesla Inc. says it will build its first factory outside the United States in Shanghai.
VLKAF PCRFY GM.WS.A GM.WS.B GM.WS.C GM GM.WSB

13
Zacks.com highlights: Hitachi, Everi Holdings, Panasonic and Turtle Beach

2018-07-11 zacks
Chicago, IL – July 11, 2018 - Stocks in this week’s article include: Hitachi, Ltd. (HTHIY - Free Report) , Everi Holdings Inc. (EVRI - Free Report) , Panasonic Corp. (PCRFY - Free Report) and Turtle Beach Corp. (HEAR - Free Report) .
LPLA SCHW.PRBCL MOV PCRFY SCHN EVRI IBKR MOVAA LSTR SFIX HOLI HEAR PETS URBN HTHIY

14
What Is Tesla's China Strategy?

2018-07-10 seekingalpha
On July 8, Tesla announced that it would be raising its prices in China in response to rising tariffs.
PCRFY GM.WS.A GM.WS.B GM.WS.C GM GM.WSB VLKAY

27
Zacks Industry Outlook Highlights: Panasonic, GoPro, Dolby Laboratories and Sony

2018-07-09 zacks
Chicago, IL – July 9, 2018 – Today, Zacks Equity Research discusses the Industry: Audio Video Production, including Panasonic Corporation (PCRFY - Free Report) , GoPro, Inc. (GPRO - Free Report) , Dolby Laboratories, Inc. (DLB - Free Report) and Sony Corporation (SNE - Free Report) .
WFC WFCNP PCRFY WFC.WS WDC WFC.PRL DLB WFC.PRJ SNEJF WFC.PRT GPRO WFC.PRR MTH WFC.PRQ WFC.PRP WFC.PRO WFC.PRN CVRR SNE WFC.PRY WFC.PRX WFC.PRW WFC.PRV DIS

0
Operations suspended at automakers and other firms across western Japan after torrential rain

2018-07-09 japantimes.co.jp
Heavy rain and flooding that inundated western parts of the country over the weekend has forced some manufacturers in the region to suspend operations, and impeded usual business activities on Monday.
PCRFY TM 7203 TYT TOYOF

4
Nikkei rebounds to 1-week high after U.S. jobs data; Nissan tumbles

2018-07-09 reuters
TOKYO, July 9 (Reuters) - Japan’s Nikkei share average rebounded to one-week highs on Monday as investors took heart from U.S. jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer’s drug.
7261 PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG MBFJF MTU

4
Nikkei rebounds to 1-week high on US jobs data

2018-07-09 thehindubusinessline
Japan's Nikkei share average rebounded to a one-week high on Monday morning as investors took heart from US jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer's drug.
7261 MZHOF PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG 8411 MBFJF MTU MFG

4
Nikkei rebounds to 1-week high after U.S. jobs data; Eisai jumps

2018-07-09 reuters
TOKYO, July 9 (Reuters) - Japan’s Nikkei share average rebounded to one-week highs on Monday morning as investors took heart from U.S. jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer’s drug.
7261 MZHOF PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG 8411 MBFJF MTU MFG

0
Evaluating Panasonic As A Long-Term Dividend Investment

2018-07-09 seekingalpha
Given my long-term investing horizon, I am always looking for quality international dividend-paying companies to add to my portfolio.
PCRFY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 69832A205